Explore All Access
Check if your research matches the topics covered in Human Vaccines and Immunotherapeutics?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Human Vaccines and Immunotherapeutics : Impact Factor & More
eISSN: 2164-554XpISSN: 2164-5515
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Human Vaccines & Immunotherapeutics is a monthly peer-reviewed medical journal covering research into vaccines and immunotherapeutics in humans. It was established in 2005 as Human Vaccines, and obtained its current name in 2012. It is published by Taylor & Francis and the editor-in-chief is Ronald Ellis (FutuRx). According to the Journal Citation Reports, the journal had a 2013 impact factor of 3.643. Less
Human Vaccines and Immunotherapeutics Key Metrics
CiteScore 
5.5
H-Index
80
Impact Factor
< 5
Scite Index
0.83 5-Year SI
SJR
Q1Immunology
SNIP
1.36
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months39%
4 to 6 months54%
7 to 9 months7%
Above 9 months0%
Did you find this useful?
Topics Covered on Human Vaccines and Immunotherapeutics
Clinical trial
Human papillomavirus
Immunization
Influenza vaccine
Polysaccharide
Streptococcus pneumoniae
Immunotherapy
Social media
Performance improvement
Measles
Randomized controlled trial
Burden of disease
Rotavirus
Public health
Confidence interval
Hepatitis B
Seroconversion
Virus
Antigen
Conjugate vaccine
Human Vaccines and Immunotherapeutics Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS INC |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | EUR 2895 | GBP 2495 | USD 3175 |
| Publication Time | 11 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | International Society for Vaccines (ISV) |
| Frequency | Monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Human Vaccines and Immunotherapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Human Vaccines and Immunotherapeutics
Timeliness for vaccination according to the expanded immunization program in children under 6 years of age in Colombia between 2014 and 2019
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Health impact of rotavirus vaccination in China
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Comment on “Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy”
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Real-world effectiveness of influenza vaccine against medical-attended influenza infection during 2023/24 season in Ili Kazakh Autonomous Prefecture, China: A test-negative, case-control study
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6–35 months of age in China: A randomized, double-blind, clinical trial
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjögren’s syndrome
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Timeliness for vaccination according to the expanded immunization program in children under 6 years of age in Colombia between 2014 and 2019
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Health impact of rotavirus vaccination in China
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Comment on “Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy”
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Real-world effectiveness of influenza vaccine against medical-attended influenza infection during 2023/24 season in Ili Kazakh Autonomous Prefecture, China: A test-negative, case-control study
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6–35 months of age in China: A randomized, double-blind, clinical trial
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjögren’s syndrome
- 31 Dec 2024
- Human Vaccines & Immunotherapeutics
Compare Similar Journals with Human Vaccines and Immunotherapeutics
Select Journals to Compare with Human Vaccines and Immunotherapeutics
Total journals - 8
You can select up to 3 Journals at a time
Vaccine
Publisher: ELSEVIER SCI LTD
Vaccines
Publisher: MDPI
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Clinical Infectious Diseases
Publisher: OXFORD UNIV PRESS INC
International Journal of Infectious Diseases
Publisher: ELSEVIER SCI LTD
Open Forum Infectious Diseases
Publisher: OXFORD UNIV PRESS INC
Expert Review of Vaccines
Publisher: TAYLOR & FRANCIS LTD
BMC Public Health
Publisher: BMC
0 Journals Selected to compare with
Human Vaccines and Immunotherapeutics
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Human Vaccines and Immunotherapeutics
How long has Human Vaccines and Immunotherapeutics been actively publishing? 
Human Vaccines and Immunotherapeutics has been in operation since 2012 till date.
What is the publishing frequency of Human Vaccines and Immunotherapeutics?
Human Vaccines and Immunotherapeutics published with a Monthly frequency.
How many articles did Human Vaccines and Immunotherapeutics publish last year?
In 2023, Human Vaccines and Immunotherapeutics publsihed 521 articles.
What is the eISSN & pISSN for Human Vaccines and Immunotherapeutics?
For Human Vaccines and Immunotherapeutics, eISSN is 2164-554X and pISSN is 2164-5515.
What is Citescore for Human Vaccines and Immunotherapeutics?
Citescore for Human Vaccines and Immunotherapeutics is 5.5.
What is the H Index for Human Vaccines and Immunotherapeutics ?
H Index for Human Vaccines and Immunotherapeutics is 80.
What is SNIP score for Human Vaccines and Immunotherapeutics?
SNIP score for Human Vaccines and Immunotherapeutics is 1.36.
What is the SJR for Human Vaccines and Immunotherapeutics?
SJR for Human Vaccines and Immunotherapeutics is Q1.
Who is the publisher of Human Vaccines and Immunotherapeutics?
TAYLOR & FRANCIS INC is the publisher of Human Vaccines and Immunotherapeutics.
